Continued licensing of hydroxyethyl starch despite high-quality data documenting harm in vulnerable patient populations: A sad day for patient safety
Acta Anaesthesiol Scand
.
2019 Jan;63(1):131-132.
doi: 10.1111/aas.13261.
Epub 2018 Sep 10.
Authors
Jon Henrik Laake
1
,
Morten Hylander Møller
2
Affiliations
1
Division of Emergencies and Critical Care, Department of Anaesthesiology, Rikshospitalet Medical Centre, Oslo University Hospital, Oslo, Norway.
2
Department of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
PMID:
30203537
DOI:
10.1111/aas.13261
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hydroxyethyl Starch Derivatives*
Patient Safety*
Plasma Substitutes
Substances
Hydroxyethyl Starch Derivatives
Plasma Substitutes